TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Paragon Care Limited ( (AU:PGC) ) just unveiled an announcement.
Paragon Care Limited has released its audited financial results for the fiscal year ending June 30, 2025. The company reported no change in profit after tax attributable to shareholders from its preliminary report. Key financial adjustments include a retrospective restatement of intangible asset valuations and a reclassification of a $125 million debt from non-current to current. Despite a significant outstanding debt from a retail pharmacy group, Paragon Care is actively working on recovery and does not foresee any impact on its financial arrangements. The company is focused on growth through both organic expansion and acquisitions, particularly in Asia.
The most recent analyst rating on (AU:PGC) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, specializing in the provision of medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and the manufacture of Blood Bank diagnostic reagents. The company serves healthcare markets in Australia, New Zealand, and Asia.
Average Trading Volume: 418,090
Technical Sentiment Signal: Sell
Current Market Cap: A$471.8M
Learn more about PGC stock on TipRanks’ Stock Analysis page.